IL32 and lung carcinoma: In conclusion, our results revealed that a potential isoform of IL-32, IL-32γ inhibits CSC self-renewal and stem cell niche, which is relevant to the growth of tumors and the recurrence of lung cancer through downregulation of the ITGAV-mediated STAT5 pathway.